ANDREW FERBER: Open Payments
NPI 1083838106 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 25 payments from 8 companies in 2025. Trend: 2023 $395 · 2024 $531 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $235 |
| Lundbeck LLC | 8 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Supernus Pharmaceuticals, Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Alkermes, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: VRAYLAR, REXULTI, CAPLYTA, Qelbree, Auvelity, SPRAVATO, VIVITROL, COBENFY.
Industry payments across FL — which companies pay providers there.
